PRECISIONBIOLOGICS
Menu
↗
Regulatory

Aesthetic practice biologics compliance basics

Compliance basics for aesthetic practices and medspas under physician supervision that purchase perinatal biologics.

Reviewed 2026-10-27

Scope for this care setting

This page covers purchasing and documentation related to aesthetic practice biologics compliance. It does not establish a clinical protocol or a permitted intended use.

Keep outcome marketing and disease claims out of the vendor evaluation. Compare suppliers on documents, logistics, and claim discipline.

Documentation to request and file

Request the current insert, certificate of analysis format, donor eligibility summary approach, sterility testing description, and shipping instructions before the first purchase order.

At receipt, match lot ID, expiration, and shipper condition to the purchase order. Incomplete packs stay open—do not close them by assumption.

Counsel and supervision checkpoints

Physician supervision structures should be documented for account verification. Intended-use questions go to clinic counsel.

Account approval is not authorization for a specific application.

Operations differences that matter

Lyophilized presentations may simplify receiving for clinics without -80°C capacity; cryopreserved presentations typically need dry-ice shipping and qualified freezers.

Confirm the insert for each SKU; do not generalize across brands or sizes.

FAQ

Frequently asked questions

Does Precision Biologics certify regulatory status for our use?+

No. Classification and intended-use determinations belong to the ordering physician and clinic counsel.

Is this legal advice?+

No. This is general information for licensed healthcare professionals.

Can account approval replace counsel review?+

No. Account verification is administrative only.

Does this page determine how we may use products discussed under aesthetic practice biologics compliance?+

No. Intended use remains with the ordering physician and clinic counsel.

Sources

  1. FDA: Minimal Manipulation and Homologous Use guidance ↗FDA
  2. 21 CFR Part 1271 ↗eCFR